Pharmacogenomics Flashcards

1
Q

three types of interindividual genetic variation that can influence pharmacotherapy

A
  • proteins involved in drug metabolism or transport (pharmacokinetic)
  • drug targets or pathway (pharmacodynamics)
  • idiosyncratic adverse drug effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

enzymes involved in drug metabolism that display polymorphism

A
  • butyrylcholinesterase (pseudocholinesterase)
  • N acetyltransferase 2
  • CYP2D6
  • Thiopurine S-methyltransferase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the function of butyrylcholinesterase

A

it metabolizes succinylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what occurs if there is a polymorphism in butyrylcholinesterase

A

-there would be a decreased rate of metabolism of succinylcholine leading to prolonged flaccid paralysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

type of inheritance of butyrylcholinesterase

A

hereditary autosomal recessive trait

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how do you treat those with polymorphism in butyrylcholinesterase

A

you treat with continued mechanical ventilation until muscle function returns to normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

function of N acetyltransferase 2 and the types

A
  • catalyzed the acetylation of isoniazid and other drugs
  • slow acetylators: metabolize isoniazid slowly and have high drug blood levels
  • fast acetylators: metabolizes isoniazid fast and have low drug blood levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inheritance of slow acetylators

A

autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

adverse effects of slow acetylators

A

since it keeps drug in plasma high and longer, it causes toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

examples of slow acetylators effects on drugs

A
  • keeps isoniazid high in blood so lead to neuropathy and hepatotoxicity
  • keeps hydralazine and procainamide high in blood leading to SLE
  • keeps sulfonamides high leading to hypersensitivity, hemolytic anemia, and SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

function of CYP2D6

A

it is part of the CYP450 family and hence metabolizes a lot of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

discuss different types of metabolizers of CYP2D6

A
  • poor metabolizers: homozygous for recessive the allele leading hence low activity
  • extensive metabolizers: heterozygous or homozygous for wild type allele
  • ultrarapid metabolizers: multiple copies of CYP2D6 genes –> up to 13 copies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

name drugs that are metabolized by CYP2D6

A
  • beta blocker metoprolol
  • neuroleptic haloperidol
  • opioids codeine and dextromethorphan
  • antidepressants: fluoxetine, imipramine, desipramine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what happens with poor metabolizers of CYP2D6 and give some examples

A

they suffer side effects when treated with standard doses as seen with metoprolol

or with codeine, it is ineffective since it needs to be converted by the enzyme to morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what happens when you give standard doses of codeine to ultrarapid metabolizers

A

overdose on codeine –> respiratory depression or respiratory arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does thiopurine S-methyltransferase (TPMT) do

A

it methylates anti cancer drugs thiopurines 6 mercaptopurine and azathioprine which is good because they have a small therapeutic window

17
Q

what happens then if one is homozygous for the polymorphism in TPMT (thiopurine S-methyltransferase)

A

they have to be given 1/10 of the standard dose so as not to have a toxic effects of the cancer drugs

18
Q

when is EGFR (epidermal growth factor receptor) expressed

A

in non-small cell lung cancer (NCLC)

19
Q

what drugs is approved for non-small cell lung cancer and how does it work

A

Gefitinib and it is an inhibitor of tyrosine kinase on EGFR

20
Q

drug that is affected by both pharmocokinetics and pharmacodynamics

A

warfarin

21
Q

lower doses of warfarin should be considered in what types of patients

A

those with polymorphism in CYP2C9 and VKORC1

22
Q

how does racemic mixture of warfarin affects its metabolism

A
  • S-warfarin is 3-5 times more potent than R-warfarin
  • S-warfarin is metabolized by CYP2C9 which has a highly polymorphic gene while R-warfarin is metabolized by CYP3A4 and other CYP isoforms
23
Q

what is idiosyncratic effect a result of

A

interaction between the drug and unique aspect of the physiology of the individual patient

24
Q

condition that causes an idiosyncratic adverse effect

A

G6PD deficiency –> formation of heinz bodies (oxidized hemoglobin)

25
Q

drugs that cause oxidative stress in G6PD deficiency

A

sulfonamides
antimalarials (primiquine and chloroquine)
chloramphenicol

26
Q

what happens to individuals with G6PD deficiency who are exposed to drugs that cause oxidative stress

A

can cause acute hemolytic anemia